Gibson, Dunn & Crutcher Adds Four Partners to NY Office

(No Ratings Yet)

Loading...

Four partners, formerly with Orrick, Herrington & Sutcliffe LLP, have joined the New York office of Gibson, Dunn & Crutcher LLP. They are Daniel Thomasch, Richard Mark, Lauren Elliot and Joseph Evall.

The group has significant experience with complex litigation on behalf of major companies in the life sciences sector, with a focus on mass torts, product liability and patent litigation. The group is well known for their work as national lead trial and appellate counsel for Wyeth (now Pfizer) in over 350 product liability cases involving claims that childhood vaccines containing the preservative thimerosal cause autistic-spectrum disorders in some children. 

Ken Doran, Chair and Managing Partner of Gibson Dunn was quoted as saying in a press release at the firm’s website: “We are pleased to welcome this exceptional group of litigators to our New York office. Their experience and success litigating on behalf of major companies in the life sciences, pharmaceutical and biotech industries complements our firmwide strengths in the areas of class actions, mass torts and patent litigation.”  

  

What

Where

Search Jobs

Thomasch was the Chair of Orrick’s Life Sciences Steering Committee. His trial practice focuses on complex product liability and patent infringement cases.

Richard Mark has a broad litigation practice with extensive experience in governmental investigations, intellectual property, product liability, commercial litigation and appellate litigation.

Lauren Elliot focuses her practice on litigating complex matters in federal and state trial and appellate courts, with an emphasis on product liability and patent litigation.

Joseph Evall’s practice focuses on patent infringement, product liability and commercial litigation involving complex issues of science and technology. 

Gibson, Dunn & Crutcher is a global law firm with nearly 1,000 attorneys and over 2,000 staff located in 15 offices around the world.